Percutaneous Nephroscopic Treatment of Parapelvic Cysts
Feasible Surgical Treatment of Peripelvic Cyst by Percutaneous Nephroscopy
1 other identifier
observational
40
1 country
1
Brief Summary
Background of the project: The surgical treatment of parapelvic cysts is currently less researched and there is no gold standard for surgery. Previously, in percutaneous nephrolithotomy, we found that fenestration and fenestration drainage in the simultaneous treatment of pararenal pelvis cysts under nephroscopic nephroscopic surgery has clear curative effect, less trauma, and quicker recovery. Objective: To clarify the safety, efficacy and long-term efficacy of percutaneous nephroscopy in the treatment of parapelvic cysts. Nature: Retrospective case cohort study. Basic research process: Retrospective collection of cases in our hospital who underwent percutaneous nephroscopy for the treatment of parapelvic cysts, and comparison of preoperative and postoperative cyst size changes and long-term efficacy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 14, 2022
CompletedFirst Posted
Study publicly available on registry
August 17, 2022
CompletedStudy Start
First participant enrolled
November 30, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedOctober 24, 2022
August 1, 2022
1 year
August 14, 2022
October 20, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
cyst size
Cyst maximum plane diameter
At least 1 year after percutaneous nephroscopy for parapelvic cysts
Study Arms (1)
Parapelvic cyst
Interventions
Eligibility Criteria
Patients who have undergone percutaneous nephroscopic surgery for parapelvic cysts
You may qualify if:
- Age 18 or older
- Has undergone percutaneous nephroscopic surgery for parapelvic cysts
- Ability to receive study follow-up
You may not qualify if:
- Patient refuses or is unable to give consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Xiangya hospital of central south university
Changsha, Hunan, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yu Cui, M.D.
Xiangya Hospital of Central South University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 14, 2022
First Posted
August 17, 2022
Study Start
November 30, 2022
Primary Completion
November 30, 2023
Study Completion
December 31, 2023
Last Updated
October 24, 2022
Record last verified: 2022-08